Divis Laboratories (DIVISLAB.NS) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
088M175M262M350M438M525M612M700MQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Operating Expenses

Selling General And Administrative ExpensesOther Expenses
025M50M75M100M125M150M175M200MQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

EBITDA

EBITDA
025M50M75M100M125M150M175M200MQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

EPS

EPSEPS Diluted
000001111Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue Variation (%)

Revenue Variation
-7-4-03610131720Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0815223038455260Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue YoY Variation (%)

Revenue YoY Variation
02581012151820Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01020304050607080Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Price-to-Earning Ratio

P/E Ratio
012253850627588100Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
01122344556687990Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
038M75M112M150M188M225M262M300MQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
001122233Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
💰 Cash Flow Statement

Operating Cash Flow

Capex To Revenue
000001111Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
038M75M112M150M188M225M262M300MQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Cash Flow to Debt Ratio

Cash At End Of Period
01M2M4M5M6M8M9M10MQ2 2026
🏦 Balance Sheet
📈 Key Metrics